We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+10.65%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$63.8B
AUM Growth
+$3.93B
(+6.6%)
Cap. Flow
-$1.01B
Cap. Flow
% of AUM
-1.58%
Top 10 Holdings %
Top 10 Hldgs %
22.75%
Holding
3,125
New
60
Increased
388
Reduced
2,521
Closed
139
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Match Group
MTCH
|
+$20M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$11.8M |
| 3 |
Thermo Fisher Scientific
TMO
|
+$11.8M |
| 4 |
Caesars Entertainment
CZR
|
+$11.1M |
| 5 |
PROG Holdings
PRG
|
+$11M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$59.2M |
| 2 |
PPLI
People Inc
PPLI
|
+$24.6M |
| 3 |
CZR
Caesars Entertainment Corporation
CZR
|
+$19.1M |
| 4 |
Teradyne
TER
|
+$16.1M |
| 5 |
CTLT
CATALENT, INC.
CTLT
|
+$15.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.2% |
| 2 | Healthcare | 13.87% |
| 3 | Financials | 12.55% |
| 4 | Consumer Discretionary | 11.87% |
| 5 | Communication Services | 9.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
STEX
2901
Streamex Corp
STEX
$83M
| $81K | ﹤0.01% |
1,641
-156
| -9% | -$11.6K |
|
2902
NextDecade
NEXT
$1.78B
| $81K | ﹤0.01% |
27,060
-4,340
| -14% | -$8.66K |
|
|
ORGS
2903
DELISTED
Orgenesis Inc. Common Stock
ORGS
| $80K | ﹤0.01% |
1,586
-514
| -24% | -$27.9K |
|
|
APTX
2904
DELISTED
Aptinyx Inc. Common Stock
APTX
| $80K | ﹤0.01% |
23,787
-5,225
| -18% | -$20K |
|
|
AVEO
2905
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
| $80K | ﹤0.01% |
13,543
+215
| +2% | +$1.06K |
|
|
CEMI
2906
DELISTED
Chembio diagnostics, Inc.
CEMI
| $79K | ﹤0.01% |
16,213
-5,990
| -27% | -$28.4K |
|
|
SBT
2907
DELISTED
Sterling Bancorp, Inc. Common Stock
SBT
| $78K | ﹤0.01% |
25,842
-3,462
| -12% | -$11.1K |
|
|
ESTE
2908
DELISTED
Earthstone Energy Inc. Class A Common Stock
ESTE
| $78K | ﹤0.01% |
30,226
-4,057
| -12% | -$11.6K |
|
2909
Abeona Therapeutics
ABEO
$413M
| $76K | ﹤0.01% |
2,983
-573
| -16% | -$36.1K |
|
2910
ASE Group
ASX
$82.2B
| $76K | ﹤0.01% |
18,532
-44,303
| -71% | -$198K |
|
2911
Safe Bulkers
SB
$774M
| $76K | ﹤0.01% |
73,331
-12,214
| -14% | -$14.1K |
|
|
RVLP
2912
DELISTED
RVL Pharmaceuticals plc Ordinary Shares
RVLP
| $76K | ﹤0.01% |
14,100
-2,151
| -13% | -$12.4K |
|
|
EEX
2913
DELISTED
Emerald Holding
EEX
| $75K | ﹤0.01% |
36,882
-5,195
| -12% | -$13.7K |
|
|
SLNO
2914
DELISTED
Soleno Therapeutics
SLNO
| $75K | ﹤0.01% |
1,995
-171
| -8% | -$5K |
|
|
RESN
2915
DELISTED
Resonant Inc.
RESN
| $75K | ﹤0.01% |
31,366
-8,535
| -21% | -$21.3K |
|
2916
Rockwell Medical
RMTI
$28.2M
| $74K | ﹤0.01% |
631
-137
| -18% | -$23.7K |
|
2917
Retractable Technologies
RVP
$20.1M
| $73K | ﹤0.01% |
10,918
-1,745
| -14% | -$13.9K |
|
|
ELOX
2918
DELISTED
Eloxx Pharmaceuticals, Inc. Common Stock
ELOX
| $73K | ﹤0.01% |
695
-150
| -18% | -$18K |
|
|
PFSW
2919
DELISTED
PFSweb, Inc.
PFSW
| $73K | ﹤0.01% |
10,975
-1,540
| -12% | -$11.4K |
|
2920
Lexicon Pharmaceuticals
LXRX
$1.1B
| $72K | ﹤0.01% |
50,159
-14,727
| -23% | -$26.2K |
|
2921
Exicure
XCUR
$8.57M
| $71K | ﹤0.01% |
270
-59
| -18% | -$19.3K |
|
2922
Wipro
WIT
$20B
| $70K | ﹤0.01% |
29,690
-75,628
| -72% | -$158K |
|
|
CKPT
2923
DELISTED
Checkpoint Therapeutics
CKPT
| $69K | ﹤0.01% |
2,561
-678
| -21% | -$16.3K |
|
2924
Intellicheck
IDN
$79.6M
| $69K | ﹤0.01% |
10,351
-2,640
| -20% | -$18.4K |
|
2925
Prospect Capital
PSEC
$1.17B
| $69K | ﹤0.01% |
13,762
-585
| -4% | -$2.94K |
|
Similar funds
VAM
RhumbLine Advisers's Q3 2020 Portfolio in Review
As of Q3 2020, RhumbLine Advisers held 3,125 positions worth $63.8B, up 6.6% from $59.9B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
RhumbLine Advisers's Q3 2020 filing shows 60 new, 388 increased, 2,521 reduced and 139 closed positions. Its largest new stake was PROG Holdings: 245,531 shares worth $11.8M. The largest sale was Apple, an estimated $59.2M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
- RhumbLine Advisers's largest Q3 2020 buy was PROG Holdings: 245,531 shares worth $11.8M.
- RhumbLine Advisers added most to Match Group in Q3 2020, an estimated $20M increase.
- RhumbLine Advisers's biggest Q3 2020 reduction was Apple, cutting an estimated $59.2M.
- RhumbLine Advisers fully exited Caesars Entertainment Corporation in Q3 2020, selling an estimated $19.1M.
- RhumbLine Advisers's ten largest holdings make up 23% of its $63.8B portfolio in Q3 2020.
- RhumbLine Advisers opened 60 new positions and closed 139 in Q3 2020.
- RhumbLine Advisers's portfolio value rose 6.6% quarter-over-quarter to $63.8B.
Based on RhumbLine Advisers's 13F filing for Q3 2020, filed 12 Nov 2020.